| Literature DB >> 30961215 |
Mingyue Sun1, Xiaoting Sun2, Ziyuan Wang3, Shuyu Guo4, Guangjiao Yu5, Huazhe Yang6.
Abstract
Photocrosslinked gelatin methacryloyl (GelMA) hydrogels have attracted great concern in the biomedical field because of their good biocompatibility and tunable physicochemical properties. Herein, different approaches to synthesize GelMA were introduced, especially, the typical method using UV light to crosslink the gelatin-methacrylic anhydride (MA) precursor was introduced in detail. In addition, the traditional and cutting-edge technologies to characterize the properties of GelMA hydrogels and GelMA prepolymer were also overviewed and compared. Furthermore, the applications of GelMA hydrogels in cell culture and tissue engineering especially in the load-bearing tissue (bone and cartilage) were summarized, followed by concluding remarks.Entities:
Keywords: GelMA; cell culture; load-bearing tissue; photocrosslink
Year: 2018 PMID: 30961215 PMCID: PMC6401825 DOI: 10.3390/polym10111290
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1The effect of hydrogel properties on differentiation of EBs. (A,B) Phase contrast images of EBs. And cell proliferation was measured by using Alamarblue assay at same time point. (C) Expression of vasculogenic (PECAM1, Tie2) and cardiogenic (alpha-MHC and Gata4) in EBs after 6 days, and in EBs before encapsulation (left line). (D) Immunostaining PECAM1 (green) (scanning confocal microscopy) in EBs encapsulated in 3 wt % GelMA (left lane) and 10 wt % PEG (right lane) after 7 days culture with nuclear co-staining (PI, red) [40]. (Reproduced with permission from Qi H et al. Adv Mater; published by John Wiley and Sons, 2010).
A summary of researches on GelMA hydrogels in load-bearing tissue and its related tissue.
| Tissue | Polymer | Cells | Aims & Achievements | Reference |
|---|---|---|---|---|
| Bone | GelMA−HA | HUVECs, MG63s | enhanced mechanical rigidity and cell functional expression, modularly engineering of biomimetic osteon. | [ |
| GelMA-nSi | hMSCs | bone regeneration without any osteoinductive factors. | [ | |
| GelMA-nHAp | preosteoblasts | increased mechanical stiffness and physiological stability, regeneration of the damaged bone tissue. | [ | |
| Alginate-GelMA | MG63, HUVECs | simplified osteon mimicking. | [ | |
| Gel/(nHAp-BMP-2) | BMSCs | increased organic/inorganic compatibility, sustainable bioactivity. | [ | |
| GelMA | HUVECs, hMSCs | microstructured bone-like tissue constructs containing a perfusable vascular lumen. | [ | |
| AlgMA-GelMA | MG63s, HUVECs | osteon-like structure by sequential assembly. | [ | |
| GelMA/PEGDA | MC3T3-E1 | bone regeneration and enhanced performance. | [ | |
| BG/GelMA | mBMSCs | improved bioactivity and stability of composites hydrogels. | [ | |
| Bio-GelMA | ADSCs | cell carriers for ADSCs, greater osteogenic differentiation of ADSCs. | [ | |
| GelMA | MSCs | vascularisation during endochondral bone repair. | [ | |
| GelMA | BMSCs | injectable stem cell-Laden GelMA microspheres, rapid osteogenic Tissue Constructs. | [ | |
| Cartilage | GelMA | meniscus fibrochondrocytes | combination of cell therapy, GelMA hydrogels, and PSL, production of graft tissue and emulation of meniscus collagen bundles. | [ |
| GGMA/GelMA DNs | NIH-3T3 | cartilage mimicking. | [ | |
| pMHMGCL/PCL- GelMA | chondrocytes | reinforced GelMA constructs. | [ | |
| PEG-GelMA-HA | DPSCs | enhanced chondrogenesis in DPSCs. | [ | |
| PEG-GelMA | hMSCs | enhanced mechanical strength. | [ | |
| G-MeHA and G-MeCS | chondrocytes | phenotypic stability and integrated cartilage tissues. | [ | |
| GelMA/PAM | chondrocytes | improved mechanical property and sustained release of growth factors. | [ | |
| GelMA-HepSH | chondrocytes | promoted cell viability and chondrocyte phenotype. | [ | |
| GelMA/gellan | chondrocytes | spatial position of chondrocytes in hydrogels and thus in defects. | [ | |
| PEGDA/GelMA | MSCs | integration of living cells, biomaterials, and biological cues. | [ | |
| endochondral bone | GelMA/CDM | MSCs | endochondral bone formation and relevant-size bone grafts. | [ |
| GelMA/HAMA-ALG/HAP | chondrocytes | improved mechanical strength and chondrogenesis. | [ | |
| vascular networks | GelMA | ECFCs and MSCs | generation of functional and 3D vascular networks. | [ |
| GelMA | ECFCs and MSCs | photopolymerization in vitro and surgical transplant in vivo. | [ | |
| PEG–GelMA | HUVECs | reproduction of the extracellular environment. | [ | |
| GelMA | MC3T3 | fabrication of microchannel networks, promoted cellular viabilityand differentiation, and the formation of endothelial monolayers. | [ | |
| GelMA | HUVECs | replicate of geometry and function of vascular networks and blood vessels. | [ | |
| GelMA, sodium alginate, and PEGTA | ECs, MSCs | improved transport of oxygen, nutrients, and waste products. | [ | |
| GelMA-alginate | ECs | generation of a scaffold with multilayer interlacing hydrogel microfibers | [ | |
| GelMA | SCAP, HUVECs | photopolymerization under an LED-light source, and promoted vasculature network formation. | [ | |
| GelMA/PCL | ECs | improved endothelium remodeling. | [ | |
| skeletal muscle | GelMA | C2C12 | 3D arrays of engineered muscle tissue. | [ |
| GelMA-CNT | C2C12 | anisotropic electrical conductivity and superior mechanical properties. | [ | |
| GelMA | C2C12 | structures and the degree of alignment of myotubes. | [ | |
| GelMA | C2C12 | enhanced myotube maturation and functionality. | [ |
Figure 23D constructed µCT tomograms of GelMA_5% (a,b) and GelMA_10% (c,d) scaffolds from day 28 of in vitro culture with MSCs [29]. (Reproduced with permission from Celikkin N et al. Journal of Biomedical Materials Research; published by John Wiley and Sons, 2017).
Figure 3(a) Compressive moduli of PCL scaffolds; (b) hydrogels alone. GelMA reinforced with PCL scaffolds and crosslinked with either (c) 25 mM or (d) 12.5 mM APS/TEMED were one order of magnitude stiffer than the scaffolds or gel alone; (e) a comparable degree of reinforcement for reinforced alginate gels; (f) Stress–strain curves of GelMA, the PCL scaffold and reinforced GelMA, approaching the curve of native cartilage (yellow) [98]. (Reproduced with permission from Visser J et al. Nature Communications; published by Springer Nature, 2015).
Figure 4(A) SEM images of GelMA/MBGNs and GelMA-G-MBGNs after soak in SBF in low magnification and high magnification. (B) XRD images of GelMA and GelMA-G-MBGNs after soak in SBF [101]. (Reproduced with permission from Xin T et al. ACS Applied Materials & Interfaces; published by American Chemical Society, 2017).
Figure 5Co-culture of vascular cells in GelMA. Constructs containing both DsRed-ECFCs and CMFDA-labeled MSCs were cultured for 2, 4 and 6 d using GelMA hydrogels with different methacrylation degrees. (a,b) Numbers of DsRed-ECFCs (a) and CMFDA-MSCs (b) were separately counted at each time point under a fluorescence microscope. (c–h) Representative confocal microscopy images of DsRed-ECFCs (c–e) and CMFDA-MSCs (f–h) after day 6 in co-culture for each methacrylation degree. [28]. (Reproduced with permission from Chen Y-C et al. Advanced Functional Materials; published by John Wiley and Sons, 2012).